Search

Search Constraints

You searched for: Author/Creator DiBernardo, Allitia

Search Results

1. 142 Withdrawal Symptom Assessment in an Esketamine Safety Study in Patients with Treatment-resistant Depression. (April 2020)

3. 156 Improvement in Disease Severity in Patients With Treatment-Resistant Depression Following Treatment With Intranasal Esketamine. (15th June 2018)

4. Disease progression model in subjects with mild cognitive impairment from the Alzheimer's disease neuroimaging initiative: CSF biomarkers predict population subtypes. (14th December 2012)

6. Montgomery‐Åsberg Depression Rating Scale factors in treatment‐resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine. Issue 4 (24th June 2022)

7. O1–02–05: Identifying multi‐analyte CSF biomarkers for Alzheimer's disease in a multi‐cohort study. (1st July 2013)